Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DUET II
NL-OMON19905Phase 2Active, not recruiting
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Oct 2016
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of urokinase in Acute limb ischaemia (ALI) and peripheral artery occlusion (PAD) (2 arms), sponsored by St. Antonius Ziekenhuis. Primary endpoint: Occurrence of hemorrhagic complications. Started Oct 2016; status: active, not recruiting.
02
Drugs
urokinase
03
Conditions
Acute limb ischaemia (ALI)peripheral artery occlusion (PAD)
Beyond the preview
Go deeper on NL-OMON19905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON19905.